s.bhattacharya
Submits third-party assay reports on material purchased directly. Based in Monterrey.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.73%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042344 | SS-31 (Elamipretide) | TFC | TFC-2604-Y3208 | Janoshik | 2026-Q3 | 99.68 | 3.43 | 95.9 | Buyer-sourced | 0 | PASS |
| AX-2026-042467 | Epitalon | Homopeptide | HOMO-2512-A5108 | Janoshik | 2026-Q2 | 99.93 | 7.81 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-042689 | Semax | ERP | ERP-2512-G9157 | VendorInvestigate | 2026-Q1 | 99.82 | 8.75 | 99.4 | Buyer-sourced | 0 | PASS |
| AX-2025-018655 | MK-677 (Ibutamoren mesylate) | QSC | QSC-2507-F5673 | Janoshik | 2025-Q3 | 99.78 | 4.37 | 94.8 | Buyer-sourced | 1 | FAIL |
| AX-2025-019344 | Dihexa | HYB | HYB-2501-T6290 | Kestrel | 2025-Q2 | 99.93 | 6.63 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019111 | Retatrutide | GSP | GSP-2411-B2857 | PeptideMeter | 2025-Q2 | 97.79 | 7.87 | 102.1 | Buyer-sourced | 0 | PASS |
| AX-2024-004181 | Semaglutide | WWB | WWB-2410-D2737 | Nordanalyt | 2024-Q4 | 99.44 | 1.53 | 104.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004840 | PT-141 (Bremelanotide) | SWB | SWB-2311-H8764 | Janoshik | 2024-Q2 | 99.07 | 3.18 | 92.7 | Buyer-sourced | 1 | MARGINAL |